333 related articles for article (PubMed ID: 22179788)
1. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.
Narayan P; Orte A; Clarke RW; Bolognesi B; Hook S; Ganzinger KA; Meehan S; Wilson MR; Dobson CM; Klenerman D
Nat Struct Mol Biol; 2011 Dec; 19(1):79-83. PubMed ID: 22179788
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β oligomers are sequestered by both intracellular and extracellular chaperones.
Narayan P; Meehan S; Carver JA; Wilson MR; Dobson CM; Klenerman D
Biochemistry; 2012 Nov; 51(46):9270-6. PubMed ID: 23106396
[TBL] [Abstract][Full Text] [Related]
3. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
Miners JS; Clarke P; Love S
Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
[TBL] [Abstract][Full Text] [Related]
4. A Disulfide-Stabilized Aβ that Forms Dimers but Does Not Form Fibrils.
Zhang S; Yoo S; Snyder DT; Katz BB; Henrickson A; Demeler B; Wysocki VH; Kreutzer AG; Nowick JS
Biochemistry; 2022 Feb; 61(4):252-264. PubMed ID: 35080857
[TBL] [Abstract][Full Text] [Related]
5. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
7. Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?
Spatharas PM; Nasi GI; Tsiolaki PL; Theodoropoulou MK; Papandreou NC; Hoenger A; Trougakos IP; Iconomidou VA
Biochim Biophys Acta Mol Basis Dis; 2022 Jul; 1868(7):166384. PubMed ID: 35292360
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Cohen SI; Linse S; Luheshi LM; Hellstrand E; White DA; Rajah L; Otzen DE; Vendruscolo M; Dobson CM; Knowles TP
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9758-63. PubMed ID: 23703910
[TBL] [Abstract][Full Text] [Related]
9. Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregates.
Scheidt T; Łapińska U; Kumita JR; Whiten DR; Klenerman D; Wilson MR; Cohen SIA; Linse S; Vendruscolo M; Dobson CM; Knowles TPJ; Arosio P
Sci Adv; 2019 Apr; 5(4):eaau3112. PubMed ID: 31001578
[TBL] [Abstract][Full Text] [Related]
10. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
[TBL] [Abstract][Full Text] [Related]
11. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
Hojati S; Ghahghaei A; Lagzian M
J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
[TBL] [Abstract][Full Text] [Related]
12. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
13. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
14. Synthetic toxic Aβ
Bobo C; Chaignepain S; Henry S; Vignaud H; Améadan A; Marchal C; Prado E; Doutch J; Schmitter JM; Nardin C; Lecomte S; Cullin C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1168-1176. PubMed ID: 28267577
[TBL] [Abstract][Full Text] [Related]
15. Clusterin inhibits Aβ
Xu L; Tian S; Peng X; Hua Y; Yang W; Chen L; Liu S; Wu W; Zhao J; He J; Wu L; Yang J; Zheng Y
J Neurochem; 2021 Jul; 158(2):444-454. PubMed ID: 33694231
[TBL] [Abstract][Full Text] [Related]
16. Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1-42).
Kim YM; Park S; Choi SY; Oh SB; Jung M; Pack CG; Hwang JJ; Tak E; Lee JY
Mol Neurobiol; 2022 Oct; 59(10):6228-6244. PubMed ID: 35904715
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
[TBL] [Abstract][Full Text] [Related]
18. From monomer to fibril: Abeta-amyloid binding to Aducanumab antibody studied by molecular dynamics simulation.
Frost CV; Zacharias M
Proteins; 2020 Dec; 88(12):1592-1606. PubMed ID: 32666627
[TBL] [Abstract][Full Text] [Related]
19. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the attachment and assembly of small amyloid-β oligomers on live cell membranes at physiological concentrations using single-molecule tools.
Nag S; Chen J; Irudayaraj J; Maiti S
Biophys J; 2010 Sep; 99(6):1969-75. PubMed ID: 20858443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
